Ascent™ Primary Knee System

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> PRODUCTS

Products	Ascent™ Primary Knee System
Company	Biomet Orthopedics, Inc
Item	Ascent™ Primary Knee System
Features	Incorporates design features of proven Biomet knee designs. Consistently restores function, stability and durability to the knee, thereby meeting the needs of total knee patients today and tomorrow. Provides instrumentation that allows reproducible results and offers the ability to choose the level of constraint intraoperatively. Achieves retinacular relief by streamlining the anterior sides of the component. Designed to enhance range of motion.
Description	The Ascent™ Total Knee System is taking total knee replacement to new heights by building on over twenty years of clinical experience. One thing has become clear in total knee replacement: surgeons need and want several choices for their patients. Surgeon choice is critical and may be the most important factor in long-term patient satisfaction. Biomet responded to this need by combining its clinical experience, extensive engineering resources, and the clinical experience of Rick Bassett, M.D. and Michael Jacobs, M.D. The combination of these resources provides Biomets surgeon customers with a clinically proven, user friendly system: the culmination of experience from the most responsive company in orthopaedics.
Info	Biomet Orthopedics, Inc Customer Service: (800) 348-9500 Web site: http://www.biomet.com

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

VIP Veterinary Pathology Verelan, Urine Venlafaxine, Serum or Plasma

(Date:12/9/2013)... According to a new market research report, ... Equipment); By Software (Packaged, Management, Application and Performance ... Global Advancements, Business Models, Technology Roadmap, Forecasts & ... is expected to reach $13.95 Billion by 2017 ... market tables and in-depth TOC on “Hadoop (Big ...

(Date:12/9/2013)... 2013 The indispensable source of thousands ... worldwide! , The World Medical Markets Fact Book 2013 ... environment. The need to understand world medical marketplaces, and ... daily, is essential. That is why this current and ... aid for every medical device industry executive. , Proven ...

(Date:12/9/2013)... 2013 TechNavio's analysts forecast the Global ... CAGR of 4.66 percent over the period 2012- 2016. ... growth is the increasing global aging population. The Global ... an increased preference for non-invasive treatment. However, the presence ... the growth of this market. , TechNavio's report, the ...

(Date:12/9/2013)... best for older breast cancer survivors to follow an ongoing ... from Jessica Dobek of the Oregon Health and Science University, ... of Cancer Survivorship . Dobek is part of a research ... bone benefit from one year of such training could be ... which could help prevent bone fractures in the long run. ...

(Date:12/9/2013)... (PRWEB) December 09, 2013 BenefitMall ... of employee benefits, HR and payroll products and services, ... for the busiest months for payroll processing ; ... related adjustments arise, but can be avoided by planning ... avoid such adjustments, freeing employers to focus on growing ...

[0] Hadoop Market (Big Data & Analytics) Worth $13.95 Billion by 2017 - New Report by MarketsandMarkets [0] The World Medical Market Fact Book 2013 [0] Global Orthopedic Bracing and Supports Market 2012-2016 [0] Keep on exercising, researchers advise older breast cancer survivors [0] ‘Tis the Season for BenefitMall to Help Small Businesses Prepare for Year-End

... to attend school should not be given doctors, sick ... International (Dtsch Arztebl Int 2010; 107[4]), child and ... of school avoidance and describe measures to tackle the ... occurs frequently and is accompanied by psychiatric symptoms. Children ...

... , The tiny tongue of a fruit fly could provide ... leading to new ways to treat obesity, according to a ... Hardin, who holds the rank of Distinguished Professor of Biology, ... examined the taste organs on Drosophila ,s proboscis (tongue), ...

... of Georgia researchers are conducting the first FDA-approved clinical trial ... cord blood can improve the quality of life for children ... children age 2-12 whose parents have stored cord blood at ... cord blood is rich in stem cells, which can divide ...

... than 1% use it as preventative; experts say drug has gotten ... a tiny fraction of women at high risk of developing breast ... comes despite the fact that experts have known since 1998 that ... 50 percent. , "This is not a surprise to me," said ...

... still has lifesaving qualities, expert stresses , THURSDAY, Feb. ... -- used for three decades to treat the disease ... of memory, a new study has found. , "Our ... cognitive functioning is known to be an important precondition ...

... ... will be discussed during the July 2010 Conference and Research Symposium. , ... (Vocus) February 11, 2010 -- Stuttering may be the result of ... are broken down and recycled, says a study in the Feb. 10 Online First issue of ...

Cached Medicine News:Health News:Tiny fruit fly could offer big clues in fight against obesity, researcher says 2 Health News:MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy 2 Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 2 Health News:Few Women at High Risk for Breast Cancer Take Tamoxifen 3 Health News:Cognitive Skills May Shrink With Tamoxifen 2 Health News:Cognitive Skills May Shrink With Tamoxifen 3 Health News:Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association 2 Health News:Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association 3

If children won't go to school Tiny fruit fly could offer big clues in fight against obesity, researcher says MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy Few Women at High Risk for Breast Cancer Take Tamoxifen Cognitive Skills May Shrink With Tamoxifen Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association

(Date:12/9/2013)... MAPLE GROVE, Minn. , Dec. 9, 2013 /PRNewswire/ ... from its global Phase 3 (PREVAIL) study of USL255 ... primary and secondary endpoints for efficacy and demonstrated favorable ... seizures (POS). The data were presented for the first ... 67 th Annual Meeting in Washington, ...

(Date:12/9/2013)... Ky. , Dec. 9, 2013 ... innovative laboratory technologies and products to hospitals, physician ... completed the acquisition of J & S Medical ... be combining forces with the goal to deliver ... office laboratories and regional reference lab markets across ...

(Date:12/9/2013)... Dec. 9, 2013 ACell, Inc., a leading ... commercialization of tissue repair products, today announced that it ... Directors with the appointment of three members. The additions ... Mullins and James D,Orta, M.D. increase the number ... Jon T. Tremmel is a board director ...

Breaking Medicine Technology:Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 4 Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures 5 LABSCO Acquires J & S Medical Associates 2 LABSCO Acquires J & S Medical Associates 3 ACell Nearly Doubles Board of Directors with Addition of Three Members 2 ACell Nearly Doubles Board of Directors with Addition of Three Members 3 ACell Nearly Doubles Board of Directors with Addition of Three Members 4 ACell Nearly Doubles Board of Directors with Addition of Three Members 5

[0] Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures [0] LABSCO Acquires J & S Medical Associates [0] ACell Nearly Doubles Board of Directors with Addition of Three Members